Arcutis Biotherapeutics Inc (ARQT)
Cost of Revenue
$41.10M
TTM · Period ending: · USD
ARQT Cost of Revenue
Latest reported$41.10Mperiod ending
Latest reported$41.10Mperiod ending
ARQT TTM Cost of Revenue ($0.00 → $41.10M)
TTM cost of revenue
High-resolution chart · PNG
ARQT cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 41,096,000 | |
| 37,649,000 | |
| 36,695,000 | |
| 31,912,000 | |
| 28,730,000 | |
| 24,702,000 | |
| 19,128,000 | |
| 14,469,000 | |
| 10,148,000 | |
| 7,460,000 | |
| 4,987,000 | |
| 3,226,000 | |
| 2,313,000 | |
| 1,771,000 | |
| 1,217,000 | |
| 943,000 | |
| 866,000 | |
| 814,000 | |
| 763,000 | |
| 718,000 | |
| 526,000 | |
| 401,000 | |
| 288,000 | |
| 182,000 | |
| 182,000 | |
| 125,000 | |
| 60,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |